← Browse by Condition
Medical Condition
metastatic solid tumor
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 1, Phase 2
NCT06163391 Phase 1
Recruiting
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer
Enrollment
40 pts
Location
United States, Belgi...
Sponsor
SOTIO Biotech AG
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT05983523 Phase 1
Recruiting
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors
Enrollment
54 pts
Location
Taiwan
Sponsor
PharmaEngine
NCT06587295 Phase 1
Recruiting
Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
Enrollment
40 pts
Location
Singapore
Sponsor
National Cancer Centre, Singap...
NCT06440005 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Enrollment
540 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc